Heparin-Induced Thrombocytopenia Management

Diagnosis and Treatment

The American Society of Hematology recommends immediate discontinuation of all heparin products when heparin-induced thrombocytopenia (HIT) is suspected, and starting argatroban as a direct thrombin inhibitor that does not cross-react with heparin antibodies in patients with severe thrombocytopenia and active thrombosis 1, 2, 3
The American College of Chest Physicians suggests that argatroban is preferred in renal failure because it is not eliminated by the kidney, making it safer in post-operative patients who may have compromised renal function 1
Initial dosing of argatroban should start at 0.5 μg/kg/min, which is lower than the 2 μg/kg/min in the package insert, to avoid bleeding, and should be adjusted to maintain aPTT 1.5-3.0 times baseline, with first check 2-3 hours after starting 1, 4
The International Society on Thrombosis and Haemostasis recommends that warfarin should never be used alone in the acute phase of HIT as it can promote venous thrombosis progression, gangrene, or skin necrosis, and can only be started after platelet count recovers to >150,000/mm³ and after at least 5-7 days of effective parenteral non-heparin anticoagulation 2, 5

The American Heart Association suggests that patients on argatroban should be monitored closely, with daily platelet counts until normalized, then twice weekly for 2 weeks, and aPTT checks every 2-3 hours after starting, with target aPTT 1.5-3.0 times baseline 1, 2
The European Society of Cardiology recommends that fondaparinux is not recommended as first-line treatment in severe HIT with active thrombosis, and that parenteral direct thrombin inhibitors like argatroban should be used instead 2, 4, 5

The American Society of Hematology warns that platelet transfusion is not recommended in acute HIT unless there is life-threatening bleeding, as it can worsen thrombosis 2
The International Society on Thrombosis and Haemostasis advises against delaying treatment and recommends starting argatroban immediately upon clinical suspicion of HIT, without waiting for confirmatory antibody testing 1, 2